Financial Data and Key Metrics Changes - Year-to-date adjusted EBITDA increased by 30%, with a third-quarter adjusted EBITDA growth of 46% to $143 million, and margins expanded by 240 basis points to 9.1% [5][11][20] - Revenue for the third quarter grew by 8.8% to $1.58 billion, or 11.7% excluding a one-time revenue adjustment [10][19] - Lease adjusted net leverage improved from 2.7 times to 2.5 times [11][21] - Full-year adjusted EBITDA guidance revised to $530 million to $555 million due to persistent industry-wide cost pressures [6][22] Business Line Data and Key Metrics Changes - Admissions growth of 5.8% in the third quarter, with year-to-date admissions up 6.7% [9][10] - Adjusted admissions increased by 2.9%, consistent with the 2025 guidance range of 2% to 3% [10][19] - Inpatient surgery growth was 9.7% in the third quarter, while outpatient surgeries declined by 1.8% [18] Market Data and Key Metrics Changes - Markets are growing two to three times faster than the national average, supported by rising care complexity [8][28] - Strong demand environment with robust surgical trends contributing to growth [5][8] Company Strategy and Development Direction - Company is focused on optimizing costs and strengthening margins through the impact program, which includes contract renegotiations and staffing adjustments [14][16] - Continued investment in outpatient services, with plans to open several urgent care and imaging centers in 2025 and 2026 [26][27] - Emphasis on maintaining a disciplined approach to strategic investments while addressing near-term earnings challenges [14][29] Management's Comments on Operating Environment and Future Outlook - Management acknowledges industry headwinds, particularly around professional fees and payer denials, which are expected to persist [12][13] - Confidence in the ability to deliver sustainable growth and long-term shareholder value despite current challenges [7][29] - Management is optimistic about the strong demand environment and the potential for margin expansion in the future [28][29] Other Important Information - Two nonrecurring items impacted financials: a $43 million revenue reduction due to a change in accounting estimate and a $54 million increase in professional and general liability reserves [22][24] - The company is taking proactive steps to address payer denials and improve revenue cycle management [16][56] Q&A Session Summary Question: What are the headwinds and tailwinds for 2026? - Management indicated it is too early to provide guidance for 2026 but noted strong demand and ongoing outpatient development as positive factors [34][36] Question: Is there consideration for a share repurchase program? - Management stated it would be premature to discuss a share repurchase program but emphasized a commitment to optimizing shareholder value [39] Question: Why won't the malpractice charge lift recurring accruals? - The charge is specific to the New Mexico market and relates to historical claims, with management confident it won't impact future accruals [42][43] Question: What drove the increase in professional fees? - The increase is attributed to pressures in radiology and anesthesia, with management expecting moderation in the future [78] Question: How is the company addressing payer denials? - Management is ramping up appeals and litigation efforts to address increased payer denials, which are widespread across managed care products [54][56] Question: What is the status of commercial negotiations for 2026? - Management reported being close to three-quarters contracted for 2026, with a focus on improving yield under contracts [107][108]

3Q25 Performance - Total revenue increased by 8.8% to $1.577 billion in 3Q25[14] - Adjusted EBITDA grew by 46.3% to $143 million in 3Q25[14] - Adjusted EBITDA margin expanded by 240 bps to 9.1% in 3Q25[14] - Operating cash flow increased by 72.1% to $154 million in 3Q25[14] Year-to-Date (YTD) Performance - Total revenue increased by 8.2% to $4.719 billion YTD[14] - Adjusted EBITDA increased by 30.1% to $411 million YTD[14] - Adjusted EBITDA margin expanded by 150 bps to 8.7% YTD[14] - Operating cash flow increased by 26.4% to $247 million YTD[14] Volume and Revenue Drivers - Admissions increased by 5.8% in 3Q25 and 6.7% YTD[12] - Adjusted admissions increased by 2.9% in 3Q25 and 2.4% YTD[12] - Net patient service revenue per adjusted admission grew by 5.8% to $17,252 in 3Q25[14] Full-Year 2025 Guidance - Total revenue guidance reaffirmed at $6.2 billion to $6.45 billion[25] - Adjusted EBITDA guidance revised to $530 million to $555 million[25] - Adjusted admissions growth expected to be between 2.0% and 3.0%[25]

Group 1: Company Presentations - HCA Healthcare, Inc. is scheduled to present at the 2025 Stephens Annual Investment Conference on November 20, 2025, at 1:00 PM CT [1] - The company will also present at the 2025 UBS Global Healthcare Conference on November 12, 2025, at 9:30 AM ET and at the 2025 Wolfe Research Healthcare Conference on November 17, 2025, at 12:00 PM ET [7] Group 2: Company Overview - HCA Healthcare is a leading provider of healthcare services in the United States, operating 191 hospitals and approximately 2,500 ambulatory care sites across 20 states and the United Kingdom [3]

Core Insights - The opening of Shenzhen Beiyi Rehabilitation Hospital marks a significant step in Ping An's strategy to integrate finance, health, and senior care, aligning with the national "Healthy China" initiative [2][10] - The hospital aims to serve up to 100,000 patients annually, providing comprehensive rehabilitation services across the Greater Bay Area [1][10] Group 1: Hospital Operations and Services - Shenzhen Beiyi Rehabilitation Hospital is operated by PKU Healthcare Group and focuses on delivering a wide range of rehabilitation services, from acute care to chronic home care [1][2] - The hospital will feature six core rehabilitation specialties: neurology, orthopedics and joints, pediatrics, geriatrics, spinal cord injury, and pain management [4] - The hospital employs advanced technologies, including AI and precision rehabilitation models, to enhance service delivery and patient outcomes [5][3] Group 2: Integrated Care Model - The hospital will implement an innovative "insurance + rehabilitation + senior care" model, facilitating seamless integration with Ping An's existing insurance and health services [6][7] - It is connected to Ping An Health Insurance's direct payment system, allowing for a streamlined payment process for patients [7] Group 3: Strategic Impact and Future Plans - The establishment of the hospital is expected to improve the quality of rehabilitation care in Shenzhen and the Greater Bay Area, contributing to the overall health and senior care ecosystem [10] - The operational experience gained from the hospital will support the development of home-based senior care services, enhancing Ping An's offerings in this sector [7][10] Group 4: Company Background and Achievements - As of September 2025, Ping An has partnerships with over 37,000 hospitals and serves nearly 250 million individual customers, with 63% benefiting from its health and senior care ecosystem [8] - Ping An is recognized as one of the largest financial services companies globally, with over RMB 12 trillion in total assets and high rankings in various global lists [11]

Core Insights - InnovAge Holding Corp and Tampa General Hospital have formed a joint venture to enhance access to the Program of All-inclusive Care for the Elderly (PACE) in the Tampa Bay region, aiming to provide comprehensive healthcare to frail seniors [1][2][3] InnovAge Overview - InnovAge is a leader in managing care for high-cost, frail seniors, focusing on enabling them to age independently at home. As of September 30, 2025, InnovAge served approximately 7,890 participants across 20 centers in six states [4] Tampa General Hospital Overview - Tampa General Hospital is a 1,529-bed not-for-profit academic health system, recognized as one of the largest hospitals in America. It is the highest-ranked hospital in Tampa Bay according to U.S. News & World Report's 2025-2026 Best Hospitals [5][6] Partnership Goals - The partnership aims to expand access to PACE's person-centered care model, which allows seniors to live independently while receiving a full range of medical, social, and in-home support, often at little to no cost for dual-eligible individuals under Medicaid and Medicare [2][3] Community Impact - The collaboration emphasizes the importance of supporting caregivers through education and respite services, thereby empowering families alongside their loved ones. The partnership also includes community support initiatives, such as donations to local organizations [3]

The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this Application Proof, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this Application Proof. Application Proof of BenQ BM Holding Cayman Corp. 明基醫院集團股份有限公司 (the "Company") (A company incorporated in the Cayman Islands with limite ...

Core Insights - The presentation covers the third quarter of 2025 for Bumrungrad Hospital Public Company Limited, highlighting key updates and financial performance [1][2]. Group 1: Management Presentations - The analyst meeting features presentations from key executives, including the Corporate Chief Strategy Officer, Chief Executive Officer, Chief Financial Officer, and a business development update [2]. - The Chief Executive Officer will provide a business update, while the Chief Financial Officer will discuss financial highlights for the third quarter and the first nine months of 2025 [2]. Group 2: Capital Expenditure Plan - The company has outlined a capital expenditure (CapEx) plan totaling THB 16.8 billion for the next five years, covering both BIH Bangkok and BIH Phuket [3]. - The CapEx plan includes new construction projects as well as improvements to the existing campus at BIH Bangkok [3].

Market Performance & Trends - Nasdaq 上涨超过 2%，标普上涨 1.5%，整体市场风险偏好较高 [2] - 半导体板块表现强势，大部分股票上涨 [2] - 黄金上涨约 2.8%，与股市和加密货币市场的风险偏好不一致 [4] - 信息技术板块上涨约 2.7%，领涨各行业板块 [8] - Palantir 股票经历投资者重新评估，此前 Michael Barry 的 Scion Asset Management 披露持有价值约 9.12 亿美元的看跌期权 [9] Company Specific News - Micron Technology 股价上涨约 6.5%，成为标普和纳斯达克 100 指数中的领涨股 [11] - TSMC 的 ADR 上涨约 3%，尽管其增长率降至 18 个月以来的最低水平 [12] - e.l.f Beauty 宣布在墨西哥 Ulta Beauty 正式推出品牌后，股价上涨超过 8% [13] - C3 股价一度上涨 12%，因有消息称该公司正在探索潜在出售或其他选择，最终收盘上涨约 3.6% [13] - Centene 股价下跌 8.8%，原因是立法者即将结束政府停摆，但未能延长《平价医疗法案》 [14] - Oscar Health 股价下跌 17.5% [16] - American Airlines 股价下跌 2.5%，该公司表示周末运营因政府停摆而面临挑战，取消了 1400 架次航班，延误超过 57000 分钟，影响了 25 万名客户 [17][19] - Met Sarah 股价下跌近 15%，此前 Novo Nordisk 拒绝进一步提高对该公司的收购要约 [20] Paramount Skydance - 公司预计总效率将提高 30 亿美元以上 [22] - 计划在 2026 年第一季度初在美国实施价格上涨 [23] - 计划额外裁员 1600 人 [24] - 预计 2026 年收入约为 300 亿美元 [30] The RealReal - 第三季度调整后每股亏损为 0.04 美元，低于预期的 0.056 美元 [24] - 第四季度营收预计为 1.88 亿至 1.91 亿美元，高于预期的 1.795 亿美元 [25]

Core Insights - Encompass Health and BSA Health System have opened the Rehabilitation Hospital of Amarillo, a 50-bed inpatient rehabilitation facility aimed at enhancing access to rehabilitation services in the Texas Panhandle region [1][4]. Company Overview - Encompass Health is the largest owner and operator of inpatient rehabilitation hospitals in the U.S., with 172 hospitals across 39 states and Puerto Rico [5]. - BSA Health System is the largest healthcare employer in the Texas Panhandle, operating a comprehensive healthcare system that includes a flagship 445-bed hospital and various specialized centers [7]. Facility Details - The Rehabilitation Hospital of Amarillo spans over 54,000 square feet and provides rehabilitation services for patients recovering from strokes, brain injuries, spinal cord injuries, amputations, and complex orthopedic conditions [2]. - Patients will receive a minimum of three hours of intensive therapy five days a week, along with 24-hour nursing care and frequent physician visits [2]. Strategic Importance - The new hospital is expected to more than double the region's capacity for inpatient rehabilitation, providing a dedicated care destination close to home for local patients [4]. - The facility is designed with patient needs in mind, featuring private rooms, advanced rehabilitation technologies, and various amenities to support recovery [3].

Skip to Main Content Skip to Search This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. Health Insurers Are Left Behind as Shutdown Fight Winds Down Updated Nov 10, 2025, 12:23 pm EST / Original Nov 10, 2025, 11:30 am EST Share Resize Reprints In this article SPX CNC OSCR HC ...